Search

Cancer progression is commonly thought of as a process involving the growth of a primary tumor followed by metastasis, in which cancer cells leave the primary tumor and spread to distant organs. A new study by researchers at Memorial Sloan Kettering Cancer Center shows that circulating tumor cells - cancer cells that break away from a primary tumor and disseminate to other areas of the body - can also return to and grow in their tumor of origin, a newly discovered process called "self-seeding."

Seven students will be awarded PhD degrees on May 19, 2021, from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK), an innovative doctoral program that prepares the next generation of basic laboratory scientists to work in research areas related to human disease with a focus on cancer.

A team of investigators from Memorial Sloan Kettering has shown for the first time that tumor growth, metastasis, and chemotherapy resistance are connected to the same molecular changes inside breast cancer cells.

MSK researchers have identified a compound that kills glioblastoma cells using a mechanism that’s completely different from earlier treatments.

Every year, GSK awards fellowships to two third-year students and six second-year students based on academic excellence.

This year's GSK Chairman’s Prize was awarded to Zhi “Zack” Zheng for his research on the SPO11 protein, which creates double-strand breaks in DNA.

Attendees met and shared ideas on cancer genetics and metastasis, stem cell biology, and more.

Sloan Kettering Institute Director Thomas J. Kelly has been named a member of the Advisory Committee to the Director (ACD) at the National Institutes of Health.